{"symbol":"BSX","fiscalQuarter":"Q3-2022","reportDate":"2022-10-26","reportTime":"BMO","status":"reported","company":{"name":"Boston Scientific Corporation","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BSX/earnings/Q3-2022","postBrief":{"headline":"Boston Scientific Misses on EPS, Stock Up 1.19%","keyNumbers":[{"metric":"EPS","actual":"$0.43","expected":"N/A","surprise":"-2.93%"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management highlighted ongoing challenges in the market but expressed confidence in long-term growth.","They noted that innovation remains a key focus area for the company."],"summary":"Overall, management acknowledged the current market conditions while emphasizing their commitment to innovation. They remain focused on long-term strategies despite short-term challenges."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Boston Scientific's earnings report shows a slight miss on EPS, which may raise concerns among some investors. However, the stock reacted positively, increasing by 1.19%, likely due to management's focus on innovation and long-term growth strategies. The lack of guidance may leave some investors cautious, but the overall tone from management was optimistic.","metaDescription":"Boston Scientific (BSX) Q3 2022 earnings: EPS missed expectations. Stock up 1.19%. Full breakdown."}}